35 research outputs found
Phase II study of mFOLFOX6 with bevacizumab (Bev) in metastatic gastric and esophageal (GE) adenocarcinoma.
No full text
Development of a protein nanoparticle platform for targeting EGFR expressing cancer cells
No full text
Polymer—Doxorubicin Conjugate with a Synthetic Peptide Ligand Targeted on Prostate Tumor
No full textSafety and efficacy of panitumumab therapy after metastatic colorectal cancer progression with cetuximab: Experience at a single Japanese institution
No full textPhase I dose-escalation trial of Sym004, an anti-EGFR antibody mixture, in Japanese patients with advanced solid tumors
No full textPreclinical evaluation of a monoclonal antibody targeting the epidermal growth factor receptor as a radioimmunodiagnostic and radioimmunotherapeutic agent
No full text
